Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Kristen Pogue's publication output changed over time?
ScholarIQpublication output · 2015–2023
Output grew0% over the shown period — from 1 works in 2015 to 1 in 2023.
1
1
2
2
2
1
1
2015201620192020202120222023
What are the most-cited papers on Kristen Pogue?
ScholarIQmost cited works
Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update
James C. Coons, Kristen Pogue, Andrew Kolodziej, Glenn A. Hirsch, M. Patricia George
S166458551. 201993 Citations
The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding
Sarah Hanigan, Jessica Das, Kristen Pogue, Geoffrey D. Barnes, Michael P. Dorsch
S108510729. 202090 Citations
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis
Alexi Vasbinder, YeeAnn Chen, Adrien Procureur, Allison Gradone, Tariq U. Azam, Daniel Perry, Husam Shadid, Elizabeth Anderson, Tonimarie Catalan, Pennelope Blakely, Namratha Nelapudi, Mohamad Fardous, Marie Bretagne, Sarah Adie, Kristen Pogue, Monika Leja, Sarah Yentz, Bryan J. Schneider, Leslie A. Fecher, Christopher D. Lao, Joe‐Elie Salem, Salim S. Hayek
S4210214127. 202282 CitationsOPEN ACCESS
The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction
David Cordwin, Theodore J. Berei, Kristen Pogue
S130832228. 202123 CitationsOPEN ACCESS
An Update on the Management of Pulmonary Arterial Hypertension and the Pharmacist’s Role
Tracy E. Macaulay, Mary B. Covell, Kristen Pogue
S182535935. 201519 Citations
Related on ScholarIQ
University School
Institution
Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update
Paper
The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding
Paper
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis
Paper
The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction
Paper
An Update on the Management of Pulmonary Arterial Hypertension and the Pharmacist’s Role
Paper